Although dysarthria is present in many neurologic diseases, its true incidence and prevalence is not fully known. Estimates and ranges vary based on the location of lesion, the nature and course of the underlying condition, and the assessment criteria used. Estimates of the prevalence of dysarthria associated with some common neurologic conditions are as follows:

• Stroke: It is estimated that 8%–60% of individuals with stroke present with dysarthria (Bogousslavsky, Melle, & Regli, 1988; Flowers, Silver, Fang, Rochon, & Martino, 2013; Jani & Gore, 2014; Kumral et al., 1988; Lawrence et al., 2001; Safaz, Kesikburun, Adigüzel, & Yilmaz, 2016; Teasell, Foley, Doherty, & Finestone, 2002; Vidović, Sinanović, Sabaskić, Haticić, & Brkić, 2011).

• Traumatic brain injury: Approximately 10%–65% of individuals with traumatic brain injury have dysarthria (Mitchell, Bowen, Tyson, Butterfint, & Conroy, 2017; Safaz, Alaca, Yasar, Tok, & Yilmaz, 2008; Sarno, 1980; Sarno, Buonaguro, & Levita, 1986; Yorkston, Honsinger, Mitsuda, & Hammen, 1989).

• Parkinson's disease: It is estimated that dysarthria affects approximately 70%–100% of individuals with Parkinson's disease (Hartelius & Svensson, 1994; Ho, Iansek, Marigliani, & Bradshaw, 1998; Logemann, Fisher, Boshes, & Blonsky, 1978; Müller et al., 2001).

• Multiple sclerosis: Between 25% and 50% of individuals with multiple sclerosis present with dysarthria at some point during the course of their disease (Darley, Brown, & Goldstein, 1972; Hartelius, Runmarker, & Andersen, 2000; Hartelius & Svensson, 1994; Yorkston, Beukelman, Strand, & Hakel, 2010).

• Amyotrophic lateral sclerosis: Dysarthria can be observed as an initial sign in up to 30% of individuals with amyotrophic lateral sclerosis, with almost all individuals developing dysarthria in later stages (Chen & Garrett, 2005; da Costa Franceschini & Mourão, 2015; Traynor et al., 2000).

Signs and symptoms of dysarthria include perceptual speech characteristics and physical signs that vary by dysarthria type (see Distinguishing Perceptual Speech Characteristics and Physical Findings by Dysarthria Type). Dysarthria can alter speech intelligibility and/or speech naturalness by disrupting one or more of the five speech subsystems—respiration, phonation, articulation, resonance, and prosody.

Perceptual Speech Characteristics

Perceptual speech characteristics are grouped below by the subsystem that contributes most to the feature, recognizing that it is difficult to associate some characteristics with specific subsystems. For example, reduced loudness may be a laryngeal problem for some individuals and a respiratory problem for others. In addition, due to the interactive nature of the speech subsystems, disruptions in one subsystem can have an impact on others. For example, impairments in respiration, phonation, articulation, and/or resonance may be responsible for prosodic deficits.

Physical Signs

Physical signs may include the following:

• Muscle wasting
• Abnormal muscle tone at rest
• Fasciculations
• Tremor (e.g., head, jaw, lip, tongue, velum)
• Weakness (e.g., tongue, lower face, velum)
• Involuntary movements (e.g., head, jaw, face, tongue, velum)
• Abnormal reflexes (e.g., hypo- or hyperactive gag reflex, jaw jerk, sucking or snout reflexes)

Many neurologic illnesses, diseases, and disorders—both acquired and congenital—can cause dysarthria. Listed below are examples of some specific etiologies, grouped into broad categories (Duffy, 2013).

• Congenital—cerebral palsy, Chiari malformation, congenital suprabulbar palsy, syringomyelia, syringobulbia

• Degenerative diseases—amyotrophic lateral sclerosis, Parkinson's disease, progressive supranuclear palsy, cerebellar degeneration, corticobasal degeneration, multiple system atrophy, Friedreich's ataxia, Huntington's disease, olivopontocerebellar atrophy, spinocerebellar ataxia, ataxia telangiectasia

• Demyelinating and inflammatory diseases—multiple sclerosis, encephalitis, Guillain-Barré and associated autoimmune syndromes, meningitis, multifocal leukoencephalopathy

• Infectious diseases—acquired immune deficiency syndrome (AIDS), Creutzfeldt-Jakob disease, herpes zoster, infectious encephalopathy, central nervous system tuberculosis, poliomyelitis

• Neoplastic diseases—central nervous system tumors; cerebral, cerebellar, or brainstem tumors; paraneoplastic cerebellar degeneration

• Other neurologic conditions—hydrocephalus, Meige syndrome, myoclonic epilepsy, neuroacanthocytosis, radiation necrosis, sarcoidosis, seizure disorder, Tourette's syndrome, Chorea gravidarum

• Toxic/metabolic diseases—botulism, carbon monoxide poisoning, central pontine myelinolysis, heavy metal or chemical toxicity, hepatocerebral degeneration, hypothyroidism, hypoxic encephalopathy, lithium toxicity, Wilson's disease

• Trauma—traumatic brain injury, chronic traumatic encephalopathy, neck trauma, neurosurgical/postoperative trauma, skull fracture

• Vascular Diseases—stroke (hemorrhagic or nonhemorrhagic), Moyamoya disease, anoxic or hypoxic encephalopathy, arteriovenous malformations

Speech-language pathologists (SLPs) play a central role in the screening, assessment, diagnosis, and treatment of persons with dysarthria. The professional roles and activities in speech-language pathology include clinical services (diagnosis, assessment, planning, and treatment); education, administration, and research; and prevention and advocacy. See ASHA's Scope of Practice in Speech-Language Pathology (ASHA, 2016).

The following roles are appropriate for SLPs:

• Screening individuals who present with possible dysarthria and determining the need for further assessment and/or referral for other services
• Conducting a culturally and linguistically relevant comprehensive assessment of speech, language, and communication in the context of the individual's unique complaints and functional needs
• Diagnosing the presence of dysarthria, and establishing its severity, characteristics, and functional impact
• Referring to, and collaborating with, other professionals to determine etiology of dysarthria, if not already known, and to facilitate access to comprehensive services
• Determining probable prognoses for improvement or progression of the dysarthria
• Making decisions about the management of dysarthria in collaboration with the patient, family, and interprofessional treatment team. See ASHA's resources on person- and family-centered care and interprofessional education/interprofessional practice (IPE/IPP)
• Developing culturally and linguistically appropriate treatment plans, providing intervention and support services, documenting progress, and determining appropriate service delivery approaches and dismissal criteria
• Counseling persons with dysarthria and their families and caregivers regarding communication-related issues and providing education aimed at preventing further complications related to dysarthria
• Consulting and collaborating with other professionals, families and caregivers, and others to facilitate program development and to provide supervision, evaluation, and/or expert testimony, as appropriate
• Providing prevention information to individuals and groups known to be at risk for etiologies associated with dysarthria, as well as to individuals working with those at risk
• Advocating for individuals with dysarthria and their families at the local, state, and national levels
• Educating other professionals on the needs of persons with dysarthria and the role that SLPs play in meeting those needs
• Remaining informed of research in the area of dysarthria, helping advance the knowledge base related to the nature and treatment of this disorder, and using evidence-based practice to guide intervention

As stated in the Code of Ethics (ASHA, 2023), SLPs who serve this population should be specifically educated and appropriately trained to do so. SLPs who diagnose and treat dysarthria must possess skills in the differential diagnosis and management of motor speech disorders. They must have specialized knowledge of

• neuroanatomy and neural functions related to craniofacial, laryngeal, and respiratory musculature and how they interact during speech production;
• how each subsystem (articulation, phonation, respiration, resonance, and prosody) can contribute to the perception of normal or abnormal speech;
• the principles of speech motor control and motor learning; and
• appropriate evidence-based assessment and intervention techniques.

Screening

Screening for dysarthria is pass/fail. It does not provide a diagnosis or a detailed description of the severity and characteristics of speech deficits associated with dysarthria but, rather, identifies the need for further assessment.

Screening may result in recommendations for

• dysarthria assessment and/or
• referral for other examinations or services.

Dysarthria Assessment

Assessment of individuals with suspected dysarthria should be conducted by an SLP using both standardized and nonstandardized measures (see assessment tools, techniques, and data sources).

The goal of the dysarthria assessment is to

• describe perceptual characteristics of the individual's speech and relevant physiologic findings;
• describe speech subsystems affected (i.e., articulation, phonation, respiration, resonance, and prosody) and the severity of impairment for each;
• identify other systems and processes that may be affected (e.g., swallowing, language, cognition); and
• assess the impact of the dysarthria on speech intelligibility and naturalness, communicative efficiency and effectiveness, and participation.

See, for example, Duffy (2013) and Lowit and Kent (2010).

The severity of the disorder does not necessarily determine the degree of disability. Speech-related disability will depend on the communication needs of the individual and the comprehensibility of his or her speech in salient contexts.

Consistent with the World Health Organization's (WHO) International Classification of Functioning, Disability, and Health (ICF) framework (ASHA, 2016; WHO, 2001), the assessment identifies and describes

• impairments in body structure and function, including underlying strengths and weaknesses in speech production and verbal/nonverbal communication;
• the individual's limitations in activity and participation, including functional status in communication, interpersonal interactions, self-care, and learning;
• contextual (environmental and personal) factors that serve as barriers to, or facilitators of, successful communication and life participation; and
• the impact of communication impairments on quality of life and functional limitations relative to the individual's premorbid social roles and abilities and the impact on his or her community.

See Person-Centered Focus on Function: Dysarthria [PDF] for an example of assessment data consistent with ICF.

Assessment may result in the following outcomes:

• Diagnosis of dysarthria and classification of dysarthria type.
• Clinical description of the dominant auditory-perceptual speech characteristics and the severity of the disorder.
• Presence of co-morbid conditions, including apraxia of speech, aphasia, cognitive-communication disorder, or swallowing disorder.
• Statement of prognosis and recommendations for intervention that relate to overall communication adequacy.
• Development of an intervention or management plan (in collaboration with patient, family, and rehabilitation team), including (a) prosthetic or surgical management or (b) augmentative and alternative communication (AAC), as appropriate. See ASHA's Practice Portal page on Augmentative and Alternative Communication.
• Identification of relevant follow-up services, including support for individuals with dysarthria.
• Referral to other professionals as needed (e.g., neurologist, psychologist).

Differentiating Among Dysarthria Types

Given the overlap in speech characteristics and other deficits across the dysarthrias, it may be difficult to determine dysarthria type, particularly when the underlying etiology is unknown (Fonville et al., 2008; Van der Graaff et al., 2009; Zyski & Weisiger, 1987). However, there are a number of distinguishing speech characteristics and physical findings that can be useful in making a differential diagnosis. See Distinguishing Perceptual Speech Characteristics and Physiologic Findings by Dysarthria Type.

Distinguishing Dysarthria From Apraxia of Speech

Listed below are characteristics and comparisons often used to distinguish dysarthria from apraxia of speech (AOS). Some dysarthria types (e.g., ataxic, hyperkinetic, and unilateral upper motor neuron) share some characteristics with AOS and can be difficult to distinguish (Bislick, McNeil, Spencer, Yorkston, & Kendall, 2017; Duffy, 2013).

• Muscle weakness or spasticity are present in several dysarthria types; AOS does not present with muscle weakness or spasticity unless there is a concomitant dysarthria.
• Several subsystems can be affected in dysarthria—unlike AOS, which is predominated by articulatory and prosodic deficits.
• In contrast to AOS, dysarthric speech may present with more consistent error patterns and is generally not influenced by automaticity of speech production, stimulus modality, and linguistic variables (Duffy, 2013).
• Other apraxic speech characteristics, such as a larger variety of articulatory errors and groping for articulatory postures, are typically not seen in dysarthria.
• Poorer performance on SMRs than on AMRs in AOS may distinguish it from ataxic dysarthria (Duffy, 2013).

For more information about AOS, see ASHA's Practice Portal page on Acquired Apraxia of Speech.

Distinguishing Dysarthria From Aphasia

Aphasia affects language comprehension and expression in both spoken and written modalities; dysarthria affects only speech production.

When an individual has both dysarthria and aphasia, and verbal expression is significantly impaired, the clinician will need to determine if the problem is motor based or language based—or some combination of the two.

Intelligibility and speech naturalness can be significantly compromised by dysarthria; however, delays during speech and/or attempts by the speaker to revise content might indicate language expression problems associated with aphasia. In such cases, it may be necessary to assess written language expression as well as oral and written language comprehension to make a definitive diagnosis. If deficits are found in these modalities, it is likely that language problems are contributing to verbal expression difficulties (Duffy, 2013). For more information about aphasia, see ASHA's Practice Portal page on Aphasia.

Cultural and Linguistic Factors

When selecting screening and assessment tests, the SLP considers the influence of cultural and linguistic factors on the individual's communication style and the potential impact of impairment on function. Variations in dialect should be taken into consideration before marking phonemes in error if they were not part of the client's repertoire or dialect prior to injury or disease.

The assessment is conducted in the language(s) used by the person with dysarthria, with the use of interpretation services as necessary. See ASHA's Practice Portal pages on Collaborating With Interpreters, Transliterators, and Translators and Bilingual Service Delivery.

Appropriate accommodations and modifications must be made to the testing process to reconcile cultural and linguistic variations. Comprehensive documentation includes descriptions of these accommodations and modifications. Scores from standardized tests should be interpreted and reported with caution in these cases.

Treatment is individualized to address the specific areas of need identified during assessment. It is provided in the language(s) used by the person with dysarthria—either by a bilingual SLP or with the use of trained interpreters, when necessary. See ASHA's Practice portal page on Collaborating With Interpreters, Transliterators, and Translators.

Consistent with the WHO's ICF framework (WHO, 2001), the goal of intervention is to help the individual achieve the highest level of independent function for participation in daily living.

Intervention is designed to

• capitalize on strengths and address weaknesses related to underlying structures and functions that affect communication across partners, activities, and settings;
• optimize retention of new motor skills by implementing principles of motor learning (Maas et al., 2008);
• facilitate the individual's activities and participation by (a) teaching new skills and compensatory strategies to the individual with dysarthria and his or her partner(s) and (b) incorporating AAC strategies if appropriate; and
• modify contextual factors that serve as barriers and enhance those that facilitate successful communication and participation, including development and use of appropriate accommodations.

For individuals with dysarthria, treatment focuses on facilitating the efficiency, effectiveness, and naturalness of communication (Rosenbek & LaPointe, 1985; Yorkston et al., 2010).

See Person-Centered Focus on Function: Dysarthria [PDF] for an example of functional goals consistent with ICF.

Treatment Approaches

Treatment can be restorative (i.e., aimed at improving or restoring impaired function) and/or compensatory (i.e., aimed at compensating for deficits not amenable to retraining).

Restorative approaches focus on improving

• speech intelligibility,
• prosody and naturalness, and
• efficiency.

Compensatory approaches focus on

• improving comprehensibility by
• increasing the speaker's use of communication strategies,
• improving listener skills and capacity, and
• altering the communication environment;
• increasing effective use of AAC options; and
• increasing use of non-AAC devices.

Treatment is not always restorative or compensatory. Sometimes, it is directed at preserving or maintaining function, such as when an individual has a slowly progressing degenerative disease.

Treatment Options

Below are brief descriptions of treatment options for addressing dysarthria. This list is not exhaustive, and the inclusion of any specific treatment does not imply endorsement from ASHA.

Treatments are grouped into (a) those that directly target the speech-production subsystems and (b) other treatment options, including communication strategies, environmental modifications, AAC, and medical/surgical interventions by other specialists.

Treatment selection depends on a number of factors, including the severity of the disorder, natural history and prognosis of the underlying neurologic disorder, the perceptual characteristics of the individual's speech and his or her communication needs, patient and family preference and engagement, and the presence and severity of co-occurring conditions (e.g., aphasia, cognitive impairment, or apraxia of speech). One or more of these co-occurring conditions might affect the individual's insight into communication limitations, ability to implement compensatory strategies such as conversational repair, or ability to benefit from some treatment approaches.

It can be important to sequence treatments. For example, respiration and phonation are usually targeted initially, but prosthetic management of velopharyngeal dysfunction may be needed first in order to achieve efficient and effective breathing and phonation for speech (Duffy, 2013; Yorkston et al., 2010).

Some treatments have benefits that extend to subsystems other than the one being targeted. For example, improving prosody can benefit naturalness and intelligibility (Patel, 2002; Yorkston et al., 2010), and increased loudness (vocal effort) may induce changes in articulation and resonance (Neel, 2009).

Treatments That Target Speech-Production Subsystems

Respiration

• Making postural adjustments (e.g., sitting upright to improve breath support for speech)
• Inhaling deeply before onset of speech utterance (known as preparatory inhalation)
• Using optimal breath groups when speaking (i.e., for each breath, speak only the number of syllables that can be comfortably produced)
• Using expiratory muscle strength training to improve strength of the expiratory muscles (the individual blows into a pressure threshold device with enough effort to overcome a preset threshold)
• Using inspiratory muscle strength training to improve strength of the inspiratory muscles to permit better sustained or repeated inspirations (the individual uses a handheld device that is set to require a minimum inspiratory pressure for inspiration to continue)
• Using maximum vowel prolongation tasks to improve duration and loudness of speech
• Using controlled exhalation tasks (air is exhaled slowly over time) to improve control of exhalation for speech
• Using nonspeech tasks to improve subglottal air pressure and respiratory support (e.g., blowing into a water glass manometer)

Phonation

• Lee Silverman Voice Treatment (LSVT®; Ramig, Bonitati, Lemke, & Horii, 1994)—an intensive program that targets high phonatory effort to improve loudness and intelligibility
• Pitch Limiting Voice Treatment (PLVT; De Swart, Willemse, Maassen, & Horstink, 2003)—a program for increasing vocal loudness without increasing pitch
• Effort closure techniques to increase adductory forces of vocal folds (e.g., pulling upward on chair seat; squeezing palms of hands together)
• Improved timing of phonation (e.g., initiating phonation at beginning of expiration)

Articulation

• Phonetic placement techniques (e.g., hands-on, descriptive, pictures) to work on positioning of the mouth, tongue, lips, or jaw during speech.
• Phonetic derivation techniques (nonspeech to speech tasks such as "blowing" to /u/).
• Exaggerated articulation (overarticulation) to emphasize phonetic placement and increase precision, sometimes called "clear speech."
• Minimal contrasts to emphasize sound contrasts necessary to differentiate one phoneme from another.
• Intelligibility drills in which the individual reads words, phrases, or sentences and attempts to repair content not understood by the listener.
• Rate modification to facilitate articulatory precision—strategies include
  • pausing at natural linguistic boundaries (e.g., using printed script marked at natural pauses);
  • using external pacing methods such as pacing boards, hand/finger tapping, and alphabet boards;
  • using auditory feedback (e.g., delayed auditory feedback or metronome);
  • using visual feedback (e.g., using computerized voice programs); and
  • using approaches that reduce speech rate without directly targeting it (e.g., increasing loudness, altering pitch variation, altering phrasing or breath patterns).

Resonance

• Prosthetic management in collaboration with other disciplines (e.g., dentists, prosthodontists)—examples include
  • palatal lift prosthesis and
  • nasal obturator to occlude nasal airflow.
• Resistance training during speech using continuous positive air pressure (Kuehn, 1997).

Prosody

• Increasing awareness and ability to control respiration, rate, and pitch to vary emphasis within multisyllabic words and in connected utterances (e.g., using scripts, marked and unmarked passages)
• Improving intonation by signaling stress with loudness, pitch, or duration
• Extending breath groups to better align with syntactic boundaries
• Using contrastive stress tasks to improve prosody and naturalness (e.g., repeating sentence with stress on different word[s])

Other Treatment Options

Communication Strategies

A variety of communication strategies can be used by the individual with dysarthria (speaker) and his or her communication partner to enhance communication when speech intelligibility or efficiency is reduced. These strategies can be used before, during, or after other treatment approaches are implemented to improve or compensate for speech deficits (see, e.g., Duffy, 2013).

Speaker strategies include

• maintaining eye contact with the communication partner;
• preparing the communication partner by gaining his or her attention and introducing the topic of conversation before speaking;
• pointing and gesturing to help convey meaning;
• looking for signs that the communication partner has or has not understood the message; and
• effectively using conversational repair strategies (e.g., restating message in different words; using gestures to help clarify message).

Communication-partner strategies include

• maintaining eye contact with the speaker;
• being an active listener and making every effort to understand the speaker's message;
• asking for clarification by asking specific questions;
• providing feedback and encouragement; and
• optimizing the ability to hear the speaker and to see the speaker's visual communication cues (e.g., by wearing prescribed hearing aids and glasses during conversations).

Environmental Modification

Environmental modification involves identifying optimal parameters to enhance comprehensibility.

These parameters include

• reducing background noise (e.g., choose a quiet setting for conversations; turn off TV, radio, and fans);
• ensuring that the environment has good lighting;
• improving proximity between the speaker and his or her communication partner; and
• using face-to-face seating for conversations.

Augmentative and Alternative Communication (AAC)

AAC involves supplementing or replacing natural speech and/or writing.

The two forms of AAC are

• unaided (e.g., manual signs, gestures, and finger spelling) and
• aided (e.g., line drawings, pictures, communication boards, tangible objects, speech-generating devices).

Other augmentative supports include voice amplifiers, artificial phonation devices (e.g., electrolarynx devices and intraoral devices), and oral prosthetics to reduce hypernasality.

See ASHA's Practice Portal page on Augmentative and Alternative Communication.

Medical/Surgical Intervention

SLPs may refer the individual to a medical specialist to assess the appropriateness of, or need for, medical interventions.

These interventions can include, for example,

• pharyngeal augmentation, pharyngeal flap, or palatal flap to treat velopharyngeal incompetency and improve resonance;
• laryngeal (vocal fold) augmentation (e.g., autologous fat or collagen), laryngoplasty, or recurrent laryngeal nerve sectioning to improve phonation; and
• pharmacological management to relieve symptoms of the underlying neurologic condition (e.g., spasticity, tremor) associated with underlying neurologic disease.

Factors Influencing Treatment Decisions

Not all individuals with dysarthria are candidates for treatment. Factors influencing decisions about treatment include the individual's communication needs, his or her motivation, and the presence of other deficits or conditions that can affect communication.

In neurodegenerative disease, treatment is often appropriate. The goal of treatment is to maximize communication at each stage of the disease, not to reverse decline (Duffy, 2013). This may include strategies to conserve energy and minimize fatigue.

Individuals with neurodegenerative diseases will need compassionate counseling to anticipate

• the potential progression of dysarthria;
• the corresponding changes in communication; and
• the types of intervention that might be appropriate at different stages (e.g., AAC, voice banking).

Cultural Factors

Views of the natural aging process and acceptance of disability vary by culture. Cultural views and preferences may not be consistent with medical approaches typically used in the U.S. health care system. It is essential that the clinician demonstrate sensitivity to family wishes when sharing potential treatment recommendations and outcomes. Clinical interactions should be approached with cultural humility.

Service Delivery

In addition to determining the optimal treatment approach for an individual with dysarthria, the clinician considers service delivery variables—such as format, provider, dosage, timing, and setting—which may have an impact on treatment outcomes.

Format—refers to the structure of the treatment session (e.g., group and/or individual). Individual treatment may be most appropriate for learning new techniques and strategies. Group treatment provides opportunities to practice techniques and strategies in a naturalistic setting and receive feedback about their effectiveness in improving comprehensibility and overall communication.

Provider—refers to the person providing the treatment (e.g., SLP, trained volunteer, family member, caregiver). In addition to skilled treatment provided by the SLP, family members and other communication partners can be trained by the SLP to provide opportunities for practice, encourage the use of strategies like AAC, and give feedback about performance in functional settings.

Dosage—refers to the frequency, intensity, and duration of service. Dosage may vary depending on individual's type and severity of disease, energy level, motivation, and degree of community support. Individuals with dysarthria may benefit from frequent and intense practice consistent with the principles of motor learning to enhance retention of speech skills (Bislick, Weir, Spencer, Kendall, & Yorkston, 2012; Kleim & Jones, 2008; Maas et al., 2008).

Timing—refers to when intervention is initiated relative to the diagnosis. Early initiation of treatment may be beneficial for learning or relearning motor patterns; however, improvements in comprehensibility using communication strategies are possible at any point. Timing for introducing prosthetic management and/or AAC may vary with the setting, the individual's preferences, and the severity and stage of disease.

Setting—refers to the location of treatment (e.g., home, community-based). Individuals may benefit from a naturalistic treatment environment that incorporates a variety of communication partners to facilitate generalization and carryover of skills.

ASHA

• Assessment Tools, Techniques, and Data Sources
• Distinguishing Perceptual Characteristics and Physiologic Findings by Dysarthria Type
• Dysarthria (Consumer Page)
• Interprofessional Education/Interprofessional Practice (IPE/IPP)
• Person- and Family-Centered Care
• Person-Centered Focus on Function: Dysarthria [PDF]
• Preferred Practice Patterns—Assessment for Motor Speech Disorders in Adults and Treatment of Motor Speech Disorders in Adults

Other Resources

This list of resources is not exhaustive and the inclusion of any specific resource does not imply endorsement from ASHA.

• Academy of Neurologic Communication Disorders and Sciences: Evidence Based Clinical Research
• ALS Association Communication Guide
• Multiple Sclerosis Society
• National Parkinson Foundation
• Speech-to-Speech
• United States Society for Augmentative/Alternative Communication

American Speech-Language-Hearing Association. (2016). Scope of practice in speech-language pathology [Scope of Practice]. Available from www.asha.org/policy/.

American Speech-Language-Hearing Association. (2023). Code of ethics [Ethics]. Available from www.asha.org/policy/.

Bislick, L. P., McNeil, M., Spencer, K. A., Yorkston, K. M., & Kendall, D. L. (2017). The nature of error consistency in individuals with acquired apraxia of speech and aphasia. American Journal of Speech-Language Pathology, 26, 611–630.

Bislick, L. P., Weir, P. C., Spencer, K. A., Kendall, D. L., & Yorkston, K. M. (2012). Do principles of motor learning enhance retention and transfer of speech skills? A systematic review. Aphasiology, 26, 709–728.

Bogousslavsky, J., Melle, G. V., & Regli, F. (1988). The Lausanne Stroke Registry: Analysis of 1,000 consecutive patients with first stroke. Stroke, 19, 1083–1092.

Chen, A., & Garrett, C. G. (2005). Otolaryngologic presentations of amyotrophic lateral sclerosis. Otolaryngology-Head and Neck Surgery, 132, 500–504.

Clark, H. M., & Solomon, N. P. (2012). Muscle tone and the speech-language pathologist: Definitions, neurophysiology, assessment, and interventions. Perspectives on Swallowing and Swallowing Disorders (Dysphagia), 21, 9–14.

da Costa Franceschini, A., & Mourão, L. F. (2015). Dysarthria and dysphagia in amyotrophic lateral sclerosis with spinal onset: A study of quality of life related to swallowing. NeuroRehabilitation, 36, 127–134.

Darley, F. L., Aronson, A. E., & Brown, J. R. (1969a). Clusters of deviant speech dimensions in the dysarthrias. Journal of Speech, Language, and Hearing Research, 12, 462–496.

Darley, F. L., Aronson, A. E., & Brown, J. R. (1969b). Differential diagnostic patterns of dysarthria. Journal of Speech, Language, and Hearing Research, 12, 246–269.

Darley, F. L., Aronson, A. E., & Brown, J. R. (1975). Motor speech disorders. Philadelphia, PA: Saunders.

Darley, F. L., Brown, J. R., & Goldstein, N. P. (1972). Dysarthria in multiple sclerosis. Journal of Speech and Hearing Research, 15, 229–245.

De Swart, B. J., Willemse, S. C., Maassen, B. A. M., & Horstink, M. W. I. M. (2003). Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology, 60, 498–500.

Duffy, J. R. (2013). Motor speech disorders: Substrates, differential diagnosis, and management. St. Louis, MO: Elsevier.

Flowers, H. L., Silver, F. L., Fang, J., Rochon, E., & Martino, R. (2013). The incidence, co-occurrence, and predictors of dysphagia, dysarthria, and aphasia after first-ever acute ischemic stroke. Journal of Communication Disorders, 46, 238–248.

Fonville, S., van der Worp, H. B., Maat, P., Aldenhoven, M., Algra, A., & van Gijn, J. (2008). Accuracy and inter-observer variation in the classification of dysarthria from speech recordings. Journal of Neurology, 255, 1545–1548.

Hartelius, L., Runmarker, B., & Andersen, O. (2000). Prevalence and characteristics of dysarthria in multiple-sclerosis incidence cohort: Relation to neurological data. Folia Phoniatrica et Logopaedica, 52, 160–177.

Hartelius, L., & Svensson, P. (1994). Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatrica et Logopaedica, 46, 9–17.

Ho, A., Iansek, R., Marigliani, C., & Bradshaw, J. L. (1998). Speech impairment in a large sample of people with Parkinson's disease. Behavioral Neurology, 11, 131–137.

Jani, M., & Gore, G. (2014). Occurrence of communication and swallowing problems in neurological disorders: Analysis of forty patients. NeuroRehabilitation, 35, 719–727.

Kent, R. D., Kent, J. F., & Rosenbek, J. C. (1987). Maximum performance tests of speech production. Journal of Speech and Hearing Disorders, 52, 367–387.

Kleim, J. A., & Jones, T. A. (2008). Principles of experience-dependent neural plasticity: Implications for rehabilitation after brain damage. Journal of Speech, Language, and Hearing Research, 51(Supp.), S225–S239.

Kuehn, D. P. (1997). The development of a new technique for treating hypernasality. American Journal of Speech-Language Pathology, 6, 5–8.

Kumral, E., Özkaya, B., Sagduyu, A., Şirin, H., Vardarli, E., & Pehlivan, M. (1988). The Ege Stroke Registry: A hospital-based study in the Aegean region, Izmir, Turkey. Cerebrovascular Disorders, 39, 315–323.

Lawrence, E. S., Coshall, C., Dundas, R., Stewart, J., Rudd, A. G., Howard, R., & Wolfe, C. D. A. (2001). Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population. Stroke, 32, 1279–1284.

Logemann, J. A., Fisher, H. B., Boshes, B., & Blonsky, E. R. (1978). Frequency and co-occurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing Disorders, 43, 47–57.

Lowit, A., & Kent, R. D. (2010). Assessment of motor speech disorders. San Diego, CA: Plural.

Maas, E., Robin, D. A., Austermann Hula, S. N., Freedman, S. E., Wulf, G., Ballard, K. J., & Schmidt, R. A. (2008). Principles of motor learning in treatment of motor speech disorders. American Journal of Speech-Language Pathology, 17, 277–298.

Mitchell, C., Bowen, A., Tyson, S., Butterfint, Z., & Conroy, P. (2017). Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database of Systematic Reviews, 1.

Müller, J., Wenning, G. K., Verny, M., McKee, A., Chaudhuri, K. R., Jellinger, . . . Litvan, I. (2001). Progression of dysarthria and dysphagia in postmortem-confirmed Parkinsonian disorders. Archives of Neurology, 58, 259–264.

Neel, A. T. (2009). Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease. Journal of Speech, Language, and Hearing Research, 52, 1021–1033.

Patel, R. (2002). Prosodic control in severe dysarthria: Preserved ability to mark the question-statement contrast. Journal of Speech, Language, and Hearing Research, 45, 858–870.

Ramig, L. O., Bonitati, C., Lemke, J., & Horii, Y. (1994). Voice treatment for patients with Parkinson disease: Development of an approach and preliminary efficacy data. Journal of Medical Speech-Language Pathology, 2, 191–209.

Rosenbek, J. C., & LaPointe, L. L. (1985). The dysarthrias: Description, diagnosis, and treatment. In D. F. Johns (Ed.), Clinical Management of neurogenic communication disorders (pp. 97–152). Boston, MA: Little, Brown and Co.

Safaz, I., Alaca, R., Yasar, E., Tok, F., & Yilmaz, B. (2008). Medical complications, physical function and communication skills in patients with traumatic brain injury: A single centre 5-year experience. Brain Injury, 22, 733–739.

Safaz, I., Kesikburun, S., Adigüzel, E., & Yilmaz, B. (2016). Determinants of disease-specific health-related quality of life in Turkish stroke survivors. International Journal of Rehabilitation Research, 39, 130–133.

Sarno, M. T. (1980). The nature of verbal impairment after closed head injury. The Journal of Nervous and Mental Disease, 168, 685–692.

Sarno, M. T., Buonaguro, A., & Levita, E. (1986). Characteristics of verbal impairment in closed head injured patients. Archive of Physical Medical Rehabilitation, 67, 400–405.

Teasell, R., Foley, N., Doherty, T., & Finestone, H. (2002). Clinical characteristics of patients with brainstem strokes admitted to a rehabilitation unit. Archives of Physical Medicine & Rehabilitation, 83, 1013–1016.

Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. M. (2000). Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House Diagnostic Criteria: A population-based study. Archives of Neurology, 57, 1171–1176.

Van der Graaff, M., Kuiper, T., Zwinderman, A., Van de Warrenburg, B., Poels, P., Offeringa, A., . . . De Visser, M. (2009). Clinical identification of dysarthria types among neurologists, residents in neurology and speech therapists. European Neurology, 61, 295–300.

Vidović, M., Sinanović, O., Sabaskić, L., Haticić, A., & Brkić, E. (2011). Incidence and types of speech disorders in stroke patients. Acta Clinica Croatica, 50, 491–494.

World Health Organization. (2001). International classification of functioning, disability, and health. Geneva, Switzerland: Author.

Yorkston, K. M., Beukelman, D. R., Strand, E., & Hakel, M. (2010). Management of motor speech disorders in children and adults. Austin, TX: Pro-Ed.

Yorkston, K. M., Honsinger, M. J., Mitsuda, P. M., & Hammen, V. (1989). The relationship between speech and swallowing disorders in head-injured patients. Journal of Head Trauma Rehabilitation, 4, 1–16.

Zyski, B. J., & Weisiger, B. E. (1987). Identification of dysarthria types based on perceptual analysis. Journal of Communication Disorders, 20, 367–378.

Acknowledgements

Content for ASHA's Practice Portal is developed through a  comprehensive process that includes multiple rounds of subject matter expert input and review. ASHA extends its gratitude to the following subject matter experts who were involved in the development of the Dysarthria in Adults page:

• Deanna Britton, PhD, CCC-SLP
• Heather M. Clark, PhD, CCC-SLP
• Joseph R. Duffy, PhD, CCC-SLP
• Nicole M. Etter, PhD, CCC-SLP
• Jessica E. Huber, PhD, CCC-SLP
• Raymond D. Kent, PhD 
• Mili S. Kuruvilla-Dugdale, PhD
• Kaitlin L. Lansford, PhD
• Antje S. Mefferd, PhD, CCC-SLP
• Amy T. Neel, PhD, CCC-SLP
• Nancy P. Solomon, PhD, CCC-SLP  

Citing Practice Portal Pages

The recommended citation for this Practice Portal page is:

American Speech-Language-Hearing Association. (n.d.). Dysarthria in Adults. (Practice Portal). Retrieved month, day, year, from www.asha.org/Practice-Portal/Clinical-Topics/Dysarthria-in-Adults/.